CTLA4 and breast cancer: Additionally, sodium ascorbate (vitamin C) has been shown to decrease tumor growth in a T-cell-dependent manner, enhance T cell infiltration into the tumor mass, potentiate clinical efficacy of immune checkpoint therapy with anti-PD-1 and anti-CTLA-4 monoclonal antibodies in murine BC models [155].